SELLAS Life Sciences Group, Inc. (SLS)
11.65
+0.39
(+3.46%)
USD |
NASDAQ |
Oct 09, 16:00
11.64
-0.01
(-0.09%)
After-Hours: 20:00
SELLAS Life Sciences Group Cash from Operations (Quarterly) : -7.588M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.588M |
| March 31, 2026 | -8.846M |
| December 31, 2025 | -4.921M |
| September 30, 2025 | -7.068M |
| June 30, 2025 | -7.33M |
| March 31, 2025 | -9.07M |
| December 31, 2024 | -7.153M |
| September 30, 2024 | -7.806M |
| June 30, 2024 | -9.682M |
| March 31, 2024 | -10.76M |
| December 31, 2023 | -4.825M |
| September 30, 2023 | -6.892M |
| June 30, 2023 | -7.566M |
| March 31, 2023 | -12.13M |
| December 31, 2022 | -5.152M |
| September 30, 2022 | -5.746M |
| June 30, 2022 | -5.761M |
| March 31, 2022 | -7.15M |
| December 31, 2021 | -4.976M |
| September 30, 2021 | -5.878M |
| June 30, 2021 | -4.898M |
| March 31, 2021 | -10.27M |
| December 31, 2020 | 3.424M |
| September 30, 2020 | -3.629M |
| June 30, 2020 | -3.381M |
| Date | Value |
|---|---|
| March 31, 2020 | -6.831M |
| December 31, 2019 | -4.176M |
| September 30, 2019 | -3.82M |
| June 30, 2019 | -4.656M |
| March 31, 2019 | -4.991M |
| December 31, 2018 | -4.555M |
| September 30, 2018 | -14.16M |
| June 30, 2018 | -6.299M |
| March 31, 2018 | -5.403M |
| December 31, 2017 | -1.742M |
| September 30, 2017 | -2.395M |
| June 30, 2017 | 3.552M |
| March 31, 2017 | -10.40M |
| December 31, 2016 | -8.00M |
| September 30, 2016 | -12.21M |
| June 30, 2016 | -11.49M |
| March 31, 2016 | -13.22M |
| December 31, 2015 | -15.28M |
| September 30, 2015 | -9.461M |
| June 30, 2015 | -11.86M |
| March 31, 2015 | -11.56M |
| December 31, 2014 | -10.74M |
| September 30, 2014 | -11.11M |
| June 30, 2014 | -12.97M |
| March 31, 2014 | -8.048M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| ImmunityBio, Inc. | -66.49M |
| AbbVie, Inc. | 3.436B |
| TG Therapeutics, Inc. | 39.26M |
| Capricor Therapeutics, Inc. | -31.49M |
| Relay Therapeutics, Inc. | -54.11M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 38.83M |
| Free Cash Flow | -28.42M |
| Free Cash Flow Per Share (Quarterly) | -0.0401 |
| Free Cash Flow to Equity (Quarterly) | -7.454M |
| Free Cash Flow to Firm (Quarterly) | -7.588M |
| Free Cash Flow Yield | -1.57% |